生物技术通报 ›› 2026, Vol. 42 ›› Issue (5): 37-50.doi: 10.13560/j.cnki.biotech.bull.1985.2026-0025

• 微生物组学专题 • 上一篇    

根际微生物组防控药用植物病害研究进展

孙卓1,2,3(), 雷梦苑1, 林红梅1,2, 吕泽良1,2, 韩忠明1,2(), 杨利民1,2()   

  1. 1.吉林农业大学中药材学院 省部共建生态恢复与生态系统管理国家重点实验室培育基地,长春 130118
    2.吉林省药用植物生态种植重点实验室,长春 130118
    3.延边长白山药业有限公司,延吉 133200
  • 收稿日期:2026-01-08 出版日期:2026-05-26 发布日期:2026-06-10
  • 通讯作者: 韩忠明,男,博士,教授,研究方向 :中药资源生态;E-mail: hanzm2008@126.com
    杨利民,男,博士,教授,研究方向 :中药资源生态与药材质量调控;E-mail: ylmh777@126.com
  • 作者简介:孙卓,男,博士,副教授,研究方向 :药用植物病害生物防控及微生态调控;E-mail: 329575068@163.com
  • 基金资助:
    吉林省科技发展计划项目(20260204099YY)

Research Advances on Rhizosphere Microbiome-mediated Control of Medicinal Plant Diseases

SUN Zhuo1,2,3(), LEI Meng-yuan1, LIN Hong-mei1,2, LYU Ze-liang1,2, HAN Zhong-ming1,2(), YANG Li-min1,2()   

  1. 1.College of Chinese Medicinal Materials, Jilin Agricultural University, State Key Laboratory of Ecological Restoration and Ecosystem Management, Changchun 130118
    2.Jilin Provincial Key Laboratory of Ecological Planting of Medicinal Plants, Changchun 130118
    3.Yanbian Changbai Mountain Pharmaceutical Co. , Ltd. , Yanji 133200
  • Received:2026-01-08 Published:2026-05-26 Online:2026-06-10

摘要:

根际微生物组作为药用植物的“第二基因组”,可通过营养竞争、重寄生、抗菌物质分泌及诱导系统抗性(induced systemic resistance, ISR)等多种机制协助植物体抵御病害侵染。在明确根际微生物组功能的基础上对其进行人为定向调控,已成为推动药用植物病害绿色管理技术升级的重要途径。本文对根际微生物组在药用植物病害防控领域的研究现状及应用情况进行系统梳理,目前研究主要围绕根际微生物组构成特征解析、病害防控机制诠释及合成菌群构建与应用三大方向,但面临化学投入品依赖导致的病害抗药性演化、土壤微生态失衡及农残超标等突出问题,且合成菌群功能稳定性不足、田间适配性差等技术瓶颈尚未突破。研究演进路径呈现阶梯式特征:早期以微生物资源筛选与单一功能验证为主,近年来则加速向精准化生防技术体系转型,突出表现为合成菌群定向装配、根际微生态调控等核心技术的融合应用,标志着技术范式从经验驱动向功能驱动的根本转变。由此提出“功能补偿装配-菌群智能构建-互作体系评价”三维协同发展框架,为药用植物病害绿色精准防控提供理论支撑与创新思路,助力中药生态农业高质量健康发展。

关键词: 药用植物, 根际微生物组, 植物微生态, 生防机制, 合成菌群

Abstract:

Rhizosphere microbiome, regarded as the “second genome” of medicinal plants, can assist plants in resisting disease infection via various mechanisms such as nutritional competition, hyperparasitism, secretion of antimicrobial metabolite, and induced systemic resistance. Based on elucidating functional attributes of the rhizospheric microbiome, artificial directional regulation has emerged as a pivotal strategy for advancing green disease management in medicinal plants. This review systematically sorts current research and applications of rhizospheric microbiomes in controlling diseases of medicinal plants, revealing three principal research thrusts, such as the parsed characteristics of rhizospheric microbiome communities, elucidation of disease biocontrol mechanisms, construction and application of synthetic microbial communities. However, current challenges still exist, including chemical input-dependent pathogen resistance evolution, soil microecological imbalance, and excessive agricultural residues. Moreover, synthetic microbial consortia exhibit inadequate functional stability and poor field adaptability, representing critical technical barriers. The evolutionary trajectory of research methodologies demonstrates a progressive shift from microbial resource screening and single-functional validation to precision biocontrol systems. Recent advancements emphasize integrated applications of synthetic microbial assembly and rhizosphere ecological modulation, marking a paradigm shift from empirical approaches to function-driven strategies. Accordingly, this study proposes a three-dimensional synergistic development framework encompassing “functional compensation assembly - consortium intelligent construction - interaction system evaluation”, aiming to provide a theoretical foundation and innovative pathway for achieving green, precise disease control in medicinal plants, and supports sustainable development in ecological agriculture of Chinese materia medica.

Key words: medicinal plant, rhizosphere microbiome, plant microecology, biocontrol mechanism, synthetic microbial community